Bruker (BRKR) Change in Accured Expenses (2011 - 2026)
Bruker (BRKR) posted Change in Accured Expenses of $11.2 million for Q1 2026, down 83.08% on a QoQ basis from $66.2 million in Q4 2025, and down 57.58% year-over-year from $26.4 million in Q1 2025.
Bruker (BRKR) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Bruker's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 57.58% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.7 million (up 103.74% YoY) and the FY2025 annual result came in at -$26.7 million, down 273.38% from the prior year.
- Change in Accured Expenses was $11.2 million for Q1 2026 at Bruker, down from $66.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $66.2 million in Q4 2025 and bottomed at -$17.2 million in Q2 2022.
- A 5-year average of $10.3 million and a median of $11.2 million in 2026 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses jumped 13200.0% — and 2024, when it sank 202.78%.
- Bruker's Change in Accured Expenses stood at $12.9 million in 2022, then slipped by 16.28% to $10.8 million in 2023, then sank by 202.78% to -$11.1 million in 2024, then jumped by 696.4% to $66.2 million in 2025, then plunged by 83.08% to $11.2 million in 2026.
- Business Quant data shows BRKR's Change in Accured Expenses at $11.2 million in Q1 2026, $66.2 million in Q4 2025, and $26.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20 Mn |
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 66.20 Mn |
| Dec 31, 2025 | 66.20 Mn |
| Mar 31, 2025 | 26.40 Mn |
| Mar 31, 2025 | 26.40 Mn |
| Dec 31, 2024 | -11.10 Mn |
| Dec 31, 2024 | -11.10 Mn |
| Sep 30, 2024 | 20.90 Mn |
| Sep 30, 2024 | 20.90 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 10.80 Mn |
| Dec 31, 2023 | 10.80 Mn |
| Sep 30, 2023 | 14.50 Mn |
| Sep 30, 2023 | 14.50 Mn |
| Jun 30, 2023 | -16.50 Mn |
| Jun 30, 2023 | -16.50 Mn |